SGLT2i treatment during AKI and its association with major adverse kidney events

• मुख्य लेखकों: Luz Alcantar-Vallin (लेखक), Jose J. Zaragoza (लेखक), Bladimir Díaz-Villavicencio (लेखक), Karla Hernandez-Morales (लेखक), Jahir R. Camacho-Guerrero (लेखक), Miguel A. Perez-Venegas (लेखक), Edgar J. Carmona-Morales (लेखक), Alexa N. Oseguera-Gonzalez (लेखक), Cesar Murguia-Soto (लेखक), Gael Chávez-Alonso (लेखक), José M. Arredondo-Dubois (लेखक), Carlos E. Orozco-Chan (लेखक), Juan A. Gómez-Fregoso (लेखक), Francisco G. Rodríguez-García (लेखक), Guillermo Navarro-Blackaller (लेखक), Ramón Medina-González (लेखक), Alejandro Martínez Gallardo-González (लेखक), Gabriela J. Abundis-Mora (लेखक), Olynka Vega-Vega (लेखक), Guillermo García-García (लेखक), Jonathan S. Chávez-Iñiguez (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

BackgroundThe association between the administration of sodium-glucose cotransporter 2 inhibitors (SGLT2is) during acute kidney injury (AKI) and the incidence of major adverse kidney events (MAKEs) is not known.MethodsThis retrospective cohort study included patients with AKI and compared the outcom...